Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Drug Delivery

MSD launches posaconazole concentrate for solution for IV in UK By PBR Staff Writer
Merck Sharp & Dohme (MSD) has launched Noxafil 300mg concentrate for solution for intravenous infusion (IV) in the UK.
Drug Research > Drug Delivery > News
FDA approves Ipsen’s Somatuline Depot Injection to treat GEP-NETs By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted approval for Ipsen Biopharmaceuticals's Somatuline Depot (lanreotide) injection 120mg to treat unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Drug Research > Drug Delivery > News New European consortium to help advance development of GSK/NIH Ebola vaccine candidate By PBR Staff Writer
GlaxoSmithKline (GSK) and three leading research institutions have formed a new European consortium to help advance development of an Ebola vaccine candidate, which is being jointly-developed by GSK and the US National Institutes of Health (NIH).
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight

View all Drug Delivery news or find news targeted to your interests
Collegium seeks FDA approval for Xtampza ER to treat chronic pain
By PBR Staff Writer
Collegium Pharmaceutical has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for Xtampza ER, its oxycodone extended-release (ER), abuse-deterrent analgesic using its DETERx technology platform, to treat chronic pain.
Drug Research > Drug Delivery > News
American Regent's injectafer assigned J Code by Centers for Medicare & Medicaid Services
American Regent, a subsidiary of Luitpold Pharmaceuticals, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted a Healthcare Common Procedure Coding System (HCPCS) code, or permanent J code, for Injectafer (ferric carboxymaltose injection), the first and only high-dose non-dextran intravenous iron for treatment of iron deficiency anemia (IDA) due to various etiologies.
Drug Research > Drug Delivery > News
Microchips completes development, clinical demonstration of drug delivery platform
Microchips Biotech, formerly MicroCHIPS, announced the completion of the development and clinical demonstration of its proprietary drug delivery technology, a microchip-based implant capable of storing and releasing precise doses of a drug on-demand or at scheduled intervals for up to 16 years.
Drug Research > Drug Delivery > News
Baxter to divest Vero Cell vaccines platform to Nanotherapeutics
Baxter International has entered into a definitive agreement to sell its proprietary Vero cell technology and related assets, including its production facility in Bohumil, Czech Republic, to Nanotherapeutics. Financial details were not disclosed.
Drug Research > Drug Delivery > News
leon-nanodrugs - Nanotechnology for Drug Formulations
leon-nanodrugs is an expert drug development company located in Munich Germany. Our core business is the reformulation of poor soluble oral and parenteral pharmaceutical active pharmaceutical ingredients (APIs) based on our proprietary nano-precipitation technology platform (MJR-technology), is under patent protection until 2030.
Drug Research > Drug Delivery > Suppliers
FDA approves Merck's HPV vaccine GARDASIL9
Merck, known as MSD outside the United States and Canada, announced that the US Food and Drug Administration (FDA) approved GARDASIL9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merck’s 9-valent human papillomavirus (HPV) vaccine, for use in girls and young women 9 to 26 years of age for the prevention of cervical, vulvar, vaginal, and anal cancers caused by HPV types 16, 18, 31, 33, 45, 52 and 58, pre-cancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, and genital warts caused by HPV types 6 and 11.
Drug Research > Drug Delivery > News
Pacira Pharmaceuticals announces changes to EXPAREL label
Pacira Pharmaceuticals, announced the US Food and Drug Administration’s (FDA) approval of changes to the EXPAREL packaging and label proposed by the company as part of a routine label supplement application, submitted on November 27, 2013.
Drug Research > Drug Delivery > News
FDA approves Sanofi Pasteur's sBLA for Fluzone Intradermal Quadrivalent vaccine for adults
By PBR Staff Writer
The US Food and Drug Administration (FDA) has approved Sanofi Pasteur's supplemental biologics license application (sBLA) for Fluzone Intradermal Quadrivalent vaccine to help protect adults aged 18-64 years against influenza (the flu) caused by influenza A subtype viruses and type B viruses.
Drug Research > Drug Delivery > News
US FDA approves Lilly's Cyramza to treat aggressive non-small cell lung cancer
By PBR Staff Writer
The US Food and Drug Administration has given its approval for the expanded use of Lilly's oncology drug, Cyramza (ramucirumab), to treat patients with metastatic non-small cell lung cancer (NSCLC).
Drug Research > Drug Delivery > News
View all Drug Delivery news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250